W. Seubwai, K. Vaeteewoottacharn, K. Umezawa, S. Okada, and S. Wongkham, “Enhanced antitumor activity of DHMEQ, a NF-κB Inhibitor, on Cholangiocarcinoma Cell Lines by Decreasing the Expression of ABC Transporters”, SRIMEDJ, vol. 28, no. 4, p. 171, Nov. 2013.